Renagel
Active substance: sevelamer
sevelamer
Centralised EU authorisationActive
Marketing holder: Sanofi Winthrop Industrie
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 2
Composition
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| US 13 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-1b1c-73d0-ba7a-f2b0a87fb79d,01a1208e-77ca-776d-b565-382bdc1c1544,01a1208f-004d-7974-b903-69268dea9489,01a12090-995b-7248-a640-bfaa78c09df5,01a12091-6771-77e3-ab3f-444cd83cc7ed;count=13 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- EMEA/H/C/000254
- Registration status
- Active
- ATC code
- V03AE02
Sources
- product · EMA · EMEA/H/C/000254 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000254 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000254 · Verified 2026-10-09